State-of-the-art imaging of infiltrative cardiomyopathies: a scientific statement from the American Heart Association
A Kottam, K Hanneman, A Schenone… - Circulation …, 2023 - Am Heart Assoc
Infiltrative cardiomyopathies comprise a broad spectrum of inherited or acquired conditions
caused by deposition of abnormal substances within the myocardium. Increased wall …
caused by deposition of abnormal substances within the myocardium. Increased wall …
Combined FDG PET/MRI versus standard-of-care imaging in the evaluation of cardiac sarcoidosis
CA Marschner, F Aloufi, M Aitken, E Cheung… - Radiology …, 2023 - pubs.rsna.org
Purpose To compare combined cardiac fluorine 18 (18F) fluorodeoxyglucose (FDG)
PET/MRI with standard-of-care evaluation using cardiac MRI, 18F-FDG PET/CT, and SPECT …
PET/MRI with standard-of-care evaluation using cardiac MRI, 18F-FDG PET/CT, and SPECT …
[HTML][HTML] Coronary microvascular disease in hypertrophic and infiltrative cardiomyopathies
AA Giannopoulos, RR Buechel… - Journal of Nuclear …, 2023 - Elsevier
Pathologic hypertrophy of the cardiac muscle is a commonly encountered phenotype in
clinical practice, associated with a variety of structural and non-structural diseases. Coronary …
clinical practice, associated with a variety of structural and non-structural diseases. Coronary …
[PDF][PDF] Kardiální sarkoidóza, myslíme na ni v diagnostice?
N Vahančíková, A Linhart, T Grus, T Adla, KM Plocová - 2021 - cksonline.cz
Sarcoidosis is a rare systemic inflammatory disease, with multiorgan involvement and the
exact cause of sarcoidosis is unknown. The most commonly affected are lungs, skin or …
exact cause of sarcoidosis is unknown. The most commonly affected are lungs, skin or …
[引用][C] THEME ARTICLES Coronary microvascular disease in hypertrophic and infiltrative cardiomyopathies
AA Giannopoulos, RR Buechel, PA Kaufmanna - 2022